双串联滤器技术治疗急性下腔静脉滤器相关血栓的应用
回顾性分析2018年7月至2022年12月共712例可回收下腔静脉滤器植入患者,其中18例滤器相关残余急性血栓超过1 mL。采用双串联滤器技术(第一枚为肾下滤器,第二枚为肾上滤器)取出滤器及血栓,技术成功率100%,14例(77.7%)完全清除血栓,无其他手术相关并发症,中位随访22.5±6.8个月无血栓症状复发。
要点
- 双串联滤器技术用于滤器相关急性血栓取出,技术成功率100%。
- 18例中14例(77.7%)完全清除残余血栓,4例(22.3%)部分清除。
- 17例(94.4%)单期行肾上滤器取出,1例(5.6%)分期取出。
核心结论
- 对于下腔静脉滤器上存在残余急性血栓且经皮机械血栓切除或导管导向溶栓后无更合适治疗的患者,双串联滤器技术是提高早期滤器取出率并同时清除残余血栓的安全方法。
研究设计与样本
- 回顾性病历审查,纳入2018年7月至2022年12月期间712例接受可回收下腔静脉滤器植入的患者。
- 滤器相关残余血栓发生于18例患者,所有病例滤器内残余急性血栓体积均超过1 mL。
- 采用双串联滤器技术(第一枚滤器为肾下下腔静脉滤器,第二枚为肾上下腔静脉滤器)取出滤器及血栓。
主要发现
- 18例中16例(88.9%)表现为滤器内残余血栓。
- 1例(5.6%)血栓位于滤器内并漂浮于滤器上方,1例(5.6%)血栓位于滤器内并位于滤器下方。
- 双串联下腔静脉滤器取出技术成功率为100%。
- 17例(94.4%)行单期肾上下腔静脉滤器取出,1例(5.6%,1/18)行两期取出。
- 残余血栓清除方面,14例(77.7%)完全清除,4例(22.3%)部分清除;1例经鞘无法清除血栓,行股静脉血栓切除术。
临床怎么用
- 对于下腔静脉滤器上存在残余急性血栓且经皮机械血栓切除或导管导向溶栓后无更合适治疗的患者,作者认为双串联滤器技术是提高早期滤器取出率并同时清除残余血栓的安全方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In this study, we examined the safety and effectiveness of removing inferior vena cava (IVC) filters with residual acute thrombosis after endovascular therapy. METHODS: A retrospective chart review of 712 patients who underwent retrievable IVC filter implantation between July 2018 and December 2022 was conducted. Residual thrombosis with the IVC filter occurred in 18 patients, and the volume of residual acute thrombosis in the IVC filter exceeded 1 mL in all cases. Angiography was performed to evaluate the size of the residual thrombosis and its position with respect to the filter. The double series filter technique (first filter, infrarenal IVC filter; second filter, suprarenal IVC filter) was used to remove the filter and thrombosis. We summarize the diagnosis, treatment, and surgical experience of these patients. RESULTS: In this study, 16 of 18 patients (88.9%) demonstrated residual thrombosis in the IVC filter. One patient (5.6%) demonstrated thrombosis located both inside and floating above the filter, and one patient (5.6%) demonstrated thrombosis located both inside and underneath the filter. The technical success rate of double series IVC filter retrieval was 100%. Seventeen patients (94.4%) underwent single-stage suprarenal IVC filter retrieval, and one patient (5.6%, 1/18) underwent two-stage retrieval. In terms of residual thrombosis removal, 14 patients (77.7%) achieved complete removal and 4 patients (22.3%) achieved partial removal. Residual thrombosis could not be removed through the sheath in one patient, so femoral vein thrombectomy was performed. No other procedure-related complications were observed. The median follow-up time was 22.5 ± 6.8 months. No recurrence of thrombus symptoms was reported, and B ultrasound and computed tomography demonstrated smooth blood flow in the IVC, renal veins, and pulmonary artery. CONCLUSIONS: For patients with residual acute thrombosis on the IVC filter and in whom there was absence of a more appropriate treatment after percutaneous mechanical thrombectomy or catheter-directed thrombolysis therapy, the double series IVC filter technique was a safe approach to improve the IVC filter retrieval rate in the early stage, as well as for simultaneous residual thrombus removal.
引用
- Yu Z, Lin C, Zeng X, et al. Application of the Double Series Filter Technique for the Treatment of Acute Inferior Vena Cava Filter-Mediated Thrombosis. Ann Vasc Surg. 2023. PMID: 37977344. doi:10.1016/j.avsg.2023.09.087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。